Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy

SIMPLE SUMMARY: Adjuvant chemotherapy following radical cystectomy is a common therapy for muscle invasive bladder cancer (MIBC) patients. No applicable biomarkers exist to predict which patients will benefit from chemotherapy. Three immune cell markers, the chemokine CC motif ligand 2 (CCL2), the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Taubert, Helge, Eckstein, Markus, Epple, Elena, Jung, Rudolf, Weigelt, Katrin, Lieb, Verena, Sikic, Danijel, Stöhr, Robert, Geppert, Carol, Weyerer, Veronika, Bertz, Simone, Kehlen, Astrid, Hartmann, Arndt, Wullich, Bernd, Wach, Sven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829767/
https://www.ncbi.nlm.nih.gov/pubmed/33467469
http://dx.doi.org/10.3390/cells10010159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7829767/
https://www.ncbi.nlm.nih.gov/pubmed/33467469
http://dx.doi.org/10.3390/cells10010159

Ejemplares similares